Cargando…

Public/private sector partnership for emerging infections.

This paper gives examples of public/private partnerships that support research, support drug development and that advance policy development, suggesting that such partnerships can advance our understanding and control of emerging infections. The investment in emerging infectious diseases from govern...

Descripción completa

Detalles Bibliográficos
Autor principal: Bond, E C
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631815/
https://www.ncbi.nlm.nih.gov/pubmed/11485645
_version_ 1782163991842258944
author Bond, E C
author_facet Bond, E C
author_sort Bond, E C
collection PubMed
description This paper gives examples of public/private partnerships that support research, support drug development and that advance policy development, suggesting that such partnerships can advance our understanding and control of emerging infections. The investment in emerging infectious diseases from government and from industry is currently much larger than that from philanthropy. Nevertheless philanthropy, even with limited dollars, is able to play a catalytic function and provide risk capitol for innovative partnerships and could in the future play an even larger role if the value of such investment is better defined and argued to recruit additional dollars to this area.
format Text
id pubmed-2631815
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-26318152009-05-20 Public/private sector partnership for emerging infections. Bond, E C Emerg Infect Dis Research Article This paper gives examples of public/private partnerships that support research, support drug development and that advance policy development, suggesting that such partnerships can advance our understanding and control of emerging infections. The investment in emerging infectious diseases from government and from industry is currently much larger than that from philanthropy. Nevertheless philanthropy, even with limited dollars, is able to play a catalytic function and provide risk capitol for innovative partnerships and could in the future play an even larger role if the value of such investment is better defined and argued to recruit additional dollars to this area. Centers for Disease Control and Prevention 2001 /pmc/articles/PMC2631815/ /pubmed/11485645 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Article
Bond, E C
Public/private sector partnership for emerging infections.
title Public/private sector partnership for emerging infections.
title_full Public/private sector partnership for emerging infections.
title_fullStr Public/private sector partnership for emerging infections.
title_full_unstemmed Public/private sector partnership for emerging infections.
title_short Public/private sector partnership for emerging infections.
title_sort public/private sector partnership for emerging infections.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631815/
https://www.ncbi.nlm.nih.gov/pubmed/11485645
work_keys_str_mv AT bondec publicprivatesectorpartnershipforemerginginfections